Durvalumab plus tremelimumab for the treatment of patients (pts) with refractory and progressive advanced thyroid carcinoma: A phase II multicohort trial (DUTHY / GETNE T1812)

被引：0

作者：

Hernando Cubero, J. ^{[1
]}

Taberna Sanz, M. ^{[2
]}

Carmona Bayonas, A. ^{[3
]}

Iglesias, L. ^{[4
]}

Grande, E. ^{[5
]}

Trigo Perez, J. M. ^{[6
]}

Grau, J. J. ^{[7
]}

Lopez-Picazo, J. M. ^{[8
]}

Castelo, B. ^{[9
]}

Alonso Gordoa, T. ^{[10
]}

Lorenzo, I. ^{[11
]}

Casado Herraez, A. ^{[12
]}

Ugidos, L. ^{[13
]}

Munarriz, J. ^{[14
]}

Lavernia, J. ^{[15
]}

Capdevila, J. ^{[1
]}

机构：

[1] Vall dHebron Univ Hosp, Med Oncol, Barcelona, Spain

[2] Hosp Duran & Reynals, ICO, Med Oncol, Lhospitalet De Llobregat, Spain

[3] Hosp Univ Morales Meseguer, Hematol & Med Oncol, Murcia, Spain

[4] Univ Hosp 12 Octubre, Oncol, Madrid, Spain

[5] MD Anderson Canc Ctr Madrid, Dept Med Oncol, Madrid, Spain

[6] Hosp Univ Virgen de la Victoria, Med Oncol, Malaga, Spain

[7] Hosp Clin Barcelona, Med Oncol, Barcelona, Spain

[8] Clin Univ Navarra, Med Oncol, Pamplona, Spain

[9] Hosp Univ La Paz, Med Oncol, Madrid, Spain

[10] Hosp Univ Ramon y Cajal, Med Oncol, Madrid, Spain

[11] Complejo Hosp Univ Vigo, Med Oncol, Vigo, Spain

[12] Hosp Clin Univ San Carlos, Dept Med Oncol, Madrid, Spain

[13] HM San Chinarro, Med Oncol, Madrid, Spain

[14] Hosp Gen Castellon, Med Oncol, Castellon de La Plana, Spain

[15] Hosp Gen Univ Valencia, Med Oncol, Valencia, Spain

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1872TiP

引用

页码：759 / 759

页数：1

共 50 条

[31] Topotecan plus ifosfamide in patients with platinum refractory advanced non small cell lung carcinoma (NSCLC): A phase II trial
Lorusso, V.
Gebbia, V.
Spada, M.
Misino, A.
Cassano, G.
Brunetti, C.
Germano, D.
Nettis, G.
Catalano, V.
Galetta, D.
Giampaglia, M.
Misino, A.
Colucci, G.
ANNALS OF ONCOLOGY, 2005, 16 : 162 - 162
[32] A randomized phase II trial of durvalumab and tremelIMUmab with gemcitabine or gemcitabine and cisplatin compared to gemcitabine and cisplatin in treatment-naive patients with CHolangio- and gallbladdEr Carcinoma (IMMUCHEC)
Vogel, A.
Boeck, S.
Waidmann, O.
Bitzer, M.
Wenzel, P.
Belle, S.
Springfeld, C.
Schulze, K.
Weinmann, A.
Lindig, U.
Trautwein, C.
Dechow, T.
Lammert, F.
Plentz, R.
Koehne, C-H.
Kunzmann, V.
Maenz, M.
Kirstein, M. M.
Saborowski, A.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S563 - S563
[33] Phase I/II clinical trial of regorafenib plus durvalumab (MEDI4736) in patients with chemotherapy-refractory advanced biliary tract cancers.
Al-Rajabi, Raed Moh'd Taiseer
Kasi, Anup
Baranda, Joaquina Celebre
Saeed, Anwaar
Li, Haoran
Bruey, Collin
Best, Shaun
Phadnis, Milind A.
Sun, Weijing
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS581 - TPS581
[34] Cabozantinib plus atezolizumab in locally advanced/metastatic adrenocortical carcinoma: Results from a multi-cohort basket phase II trial, CABATEN/GETNE-T1914.
Grande, Enrique
Vinuales, Marta Benavent
Molina-Cerrillo, Javier
Teule, Alex
Jimenez-Fonseca, Paula
Carmona-Bayonas, Alberto
Lopez, Carlos
Garcia-Carbonero, Rocio
Hierro, Cinta
Custodio, Ana
Martinez-Trufero, Javier
Llanos, Marta
Sevilla, Isabel
Hernando, Jorge
Jimenez, Inmaculada Gallego
Alonso-Gordoa, Teresa
Gallego, Javier
Capdevila, Jaume
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 1 - 1
[35] Responses to Cabozantinib plus Atezolizumab in a wide population of advanced and progressive neuroendocrine neoplasms (NENs): A prospective multi-cohort basket phase II Trial (CABATEN / GETNE-T1914)
Molina-Cerrillo, J.
Grande, E.
Benavent, M.
Garcia-Carbonero, R.
Teule, A.
Custodio, A.
Jimenez-Fonseca, P.
Hierro, C.
Lopez, C.
Sevilla, I
Llanos, M.
Capdevila, J.
JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 245 - 245
[36] CCTG CO.26: Updated analysis and impact of plasma-detected microsatellite stability (MSS) and tumor mutation burden (TMB) in a phase II trial of durvalumab (D) plus tremelimumab (T) and best supportive care (BSC) versus BSC alone in patients (pts) with refractory metastatic colorectal carcinoma (rmCRC).
Chen, Eric Xueyu
Jonker, Derek J.
Loree, Jonathan M.
Kennecke, Hagen F.
Berry, Scott R.
Couture, Felix
Ahmad, Chaudhary E.
Goffin, John R.
Kavan, Petr
Harb, Mohammed
Colwell, Bruce
Samimi, Setareh
Samson, Benoit
Abbas, Tahir
Aucoin, Nathalie
Aubin, Francine
Koski, Sheryl L.
Wei, Alice Chia-chi
Tu, Dongsheng
O'Callaghan, Christopher J.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[37] PAZONET: Results of a phase II trial of pazopanib as a sequencing treatment in progressive metastatic neuroendocrine tumors (NETs) patients (pts), on behalf of the Spanish task force for NETs (GETNE)-NCT01280201
Grande Pulido, Enrique
Castellano, Daniel E.
Garcia-Carbonero, Rocio
Teule, Alex
Duran, Ignacio
Fuster, Jose
Sevilla, Isabel
Escudero, P.
Sastre, Javier
Capdevila, Jaume
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[38] MYSTIC: a global, phase 3 study of durvalumab (MEDI4736) plus tremelimumab combination therapy or durvalumab monotherapy versus platinum-based chemotherapy (CT) in the first-line treatment of patients (pts) with advanced stage IV NSCLC
Peters, S.
Antonia, S.
Goldberg, S. B.
Heymach, J. V.
Kim, E. S.
Nakagawa, K.
Papadimitrakopoulou, V.
Mukhopadhyay, P.
McIntosh, S.
Rizvi, N. A.
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S139 - S140
[39] Final results of the TALENT trial (GETNE1509): a prospective multicohort phase II study of lenvatinib in patients (pts) with G1/G2 advanced pancreatic (panNETs) and gastrointestinal (giNETs) neuroendocrine tumors (NETs).
Capdevila, Jaume
Fazio, Nicola
Lopez, Carlos Lopez
Teule, Alex
Valle, Juan W.
Tafuto, Salvatore
Custodio, Ana B.
Reed, Nicholas
Raderer, Markus
Grande, Enrique
Garcia-Carbonero, Rocio
Jimenez-Fonseca, Paula
Alonso, Vicente
Antonuzzo, Lorenzo
Spallanzani, Andrea
Berruti, Alfredo
Sevilla, Isabel
Munoa, Adelaida La Casta
Hernando-Cubero, Jorge
Ibrahim, Toni
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[40] Phase II trial of sorafenib plus doxorubicin (SD) in patients (Pts) with advanced hepatocellular carcinoma (HCC) after progression of disease (PD) on sorafenib (S).
El Dika, Imane H.
Capanu, Marinela
Chou, Joanne F.
Harding, James J.
Hrabovsky, Anna D.
Do, Richard K. G.
Shia, Jinru
Germino, Joseph
O'Reilly, Eileen Mary
Abou-Alfa, Ghassan K.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

← 1 2 3 4 5 →